1.Successful management of cancer related pruritus by using mirtazapine: a case report
Tomohiro Nishi ; Etsuko Warita ; Junko Uemoto ; Kei Onodera ; Mie Yasuhiro
Palliative Care Research 2012;7(2):556-561
Introduction: It is difficult to manage that pruritus complicated with jaundice, for invalidity of almost all antihistamines. Recently, effects of paroxetine for pruritus are reported, but the report to invalid cases of paroxetine is rare. We report a case treated effectively with mirtazapine for pruritus of the paroxetine invalid. Case report: A 56-years old woman was diagnosed cancer of head of pancreas and peritoneal dissemination.After stenting by a plastic stent for obstructive jaundice in previous hospital, she came to our hospital. But, her total bilirubin (T-bil) were very high (9.9 mg/dl), and she was suffering from systemic pruritus. The NRS (numerical rating scale) score for pruritus was 9-10. Though she was prescribed an antihistamine in previous hospital, it was invalid. We had changed it to paroxetine, but pruritus were protraction two weeks later. After changing it to mirtazapine, the pruritus became NRS 1 on the next day, and recurrence was not seen subsequently. Conclusion: For pruritus of the paroxetine invalid, mirtazapine is important as one of the choices.
2.Gastric Xanthomas and Fundic Gland Polyps as Endoscopic Risk Indicators of Gastric Cancer
Kentaro YAMASHITA ; Ryo SUZUKI ; Toshiyuki KUBO ; Kei ONODERA ; Tomoya IIDA ; Mayuko SAITO ; Yoshiaki ARIMURA ; Takao ENDO ; Masanori NOJIMA ; Hiroshi NAKASE
Gut and Liver 2019;13(4):409-414
BACKGROUND/AIMS: Fundic gland polyps (FGPs), hyperplastic polyps (HPs), and xanthomas (XTs) are common benign gastric lesions that can be diagnosed by endoscopic appearance alone in most cases. The aim of this study was to evaluate associations between gastric cancer and these benign lesions. METHODS: Two expert endoscopists reviewed a series of gastroscopy images. FGPs, HPs, and XTs were diagnosed by endoscopic appearance, whereas all gastric cancers were confirmed pathologically. RESULTS: Of the 1,227 patients reviewed, 114 (9.3%) had a concurrent or past history of gastric cancer. The overall prevalences of FGPs, HPs and XTs were 9.4%, 6.3% and 14.2%, respectively. HPs and XTs coexisted in 1.6% of patients, whereas other combinations were rarer. XTs were observed in 39.3% and 11.5% of patients with and without gastric cancer, respectively (p<0.001). In contrast, no gastric cancer patients had FGPs, whereas 10.4% of patients without cancer had FGPs (p<0.001). The prevalence of HPs was similar between the two groups (8.8% and 6.0% of patients with and without cancer, respectively, p=0.29). Multivariate and Mantel-Haenszel analyses demonstrated that XTs were positively associated and FGPs were negatively associated with gastric cancer. CONCLUSIONS: XTs and FGPs might be useful as endoscopic risk indicators for monitoring gastric cancer.
Gastroscopy
;
Humans
;
Polyps
;
Prevalence
;
Stomach Neoplasms
;
Xanthomatosis
3.A Prospective Multicenter Study Evaluating Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Prescribed Antithrombotic Agents.
Kazumichi KAWAKUBO ; Kei YANE ; Kazunori ETO ; Hirotoshi ISHIWATARI ; Nobuyuki EHIRA ; Shin HABA ; Ryusuke MATSUMOTO ; Keisuke SHINADA ; Hiroaki YAMATO ; Taiki KUDO ; Manabu ONODERA ; Toshinori OKUDA ; Yoko TAYA-ABE ; Shuhei KAWAHATA ; Kimitoshi KUBO ; Yoshimasa KUBOTA ; Masaki KUWATANI ; Hiroshi KAWAKAMI ; Akio KATANUMA ; Michihiro ONO ; Tsuyoshi HAYASHI ; Minoru UEBAYASHI ; Naoya SAKAMOTO
Gut and Liver 2018;12(3):353-359
BACKGROUND/AIMS: Although the risk of bleeding after endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is low, the safety of EUS-FNA in patients prescribed antithrom-botic agents is unclear. Therefore, this study evaluated the incidence of bleeding after EUS-FNA in those patients. METHODS: Between September 2012 and September 2015, patients who were prescribed antithrombotic agents underwent EUS-FNA at 13 institutions in Japan were prospectively enrolled in the study. The antithrombotic agents were managed according to the guidelines of the Japanese Gastrointestinal Endoscopy Society. The rate of bleeding events, thromboembolic events and other complications within 2 weeks after EUS-FNA were analyzed. RESULTS: Of the 2,629 patients who underwent EUS-FNA during the study period, 85 (62 males; median age, 74 years) patients were included in this stduy. Two patients (2.4%; 95% confidence interval [CI], 0.6% to 8.3%) experienced bleeding events. One patient required surgical intervention for hemothorax 5 hours after EUS-FNA, and the other experienced melena 8 days after EUS-FNA and required red blood cell transfusions. No thromboembolic events occurred (0%; 95% CI, 0.0% to 4.4%). Three patients (3.5%; 95% CI, 1.2% to 10.0%) experienced peri-puncture abscess formation. CONCLUSIONS: The rate of bleeding after EUS-FNA in patients prescribed antithrombotic agents might be considerable.
Abscess
;
Asian Continental Ancestry Group
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration*
;
Endoscopy, Gastrointestinal
;
Erythrocyte Transfusion
;
Fibrinolytic Agents*
;
Hemorrhage*
;
Hemothorax
;
Humans
;
Incidence
;
Japan
;
Male
;
Melena
;
Prospective Studies*